Formosa Pharmaceuticals, Inc. (6838) Stock Price & Analysis
6838 Stock Chart & Stats
- Day’s Range
- TWD 20.70 - TWD 21.90
- 52-Week Range
- TWD 20.70 - TWD 33.30
- Previous Close
- TWD 22.00
- Volume
- N/A
- Average Volume (3M)
- 118.52K
- Market Cap
- TWD 3.17B
- Enterprise Value
- TWD 2.48B
- Total Cash (Recent Filing)
- N/A
- Total Debt (Recent Filing)
- N/A
- Price to Earnings (P/E)
- ―
- Beta
- 0.66
- Next Earnings
- Nov 18, 2026 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
6838 FAQ
What was Formosa Pharmaceuticals, Inc.’s price range in the past 12 months?
What is Formosa Pharmaceuticals, Inc.’s market cap?
When is Formosa Pharmaceuticals, Inc.’s upcoming earnings report date?
How were Formosa Pharmaceuticals, Inc.’s earnings last quarter?
Is Formosa Pharmaceuticals, Inc. overvalued?
Does Formosa Pharmaceuticals, Inc. pay dividends?
What is Formosa Pharmaceuticals, Inc.’s EPS estimate?
How many shares outstanding does Formosa Pharmaceuticals, Inc. have?
What happened to Formosa Pharmaceuticals, Inc.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Formosa Pharmaceuticals, Inc.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Formosa Pharmaceuticals, Inc.
Formosa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in developing drug candidates for ophthalmology, oncology, and anti-infectives in Taiwan. It is involved in developing TSY-110, an antibody-drug conjugate; and TSY-0210, an antibiotic for drug resistant infections. The company also develops APP13002 to treat infectious eye diseases, such as conjunctivitis, keratitis, blepharitis, and meibomian gland dysfunction; and MPT0E028, a novel pan- histone deacetylase inhibitor for solid tumors, such as hepatomas and colorectal cancer. It has a strategic partnership with Eyenovia, Inc. for the development of novel ophthalmic therapeutic; and Singapore Eye Research Institute to develop ophthalmic formulations for corneal diseases. Formosa Pharmaceuticals, Inc. was founded in 2010 and is headquartered in Taipei City, Taiwan.
- Sector
- General
- Industry
- Biotechnology
- CEO
- Erick Co
- Website
- www.formosapharma.com
- Address
- No. 57, Fuxing North Road, Taipei, 105, TW
Formosa Pharmaceuticals, Inc. (6838) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 2 | 14 |
| Technical Analysis | 6 | 2 | 2 |
| Moving Averages | 0 | 0 | 12 |

